High Demand Drives Business Sales for Hematology Analyzers

Hematology analyzers are experiencing high market filtration and growth in response to COVID-19. Expected to grow by 8% by 2027, the market is in step with medical trends. As researchers attempt to monitor patients without spreading disease, the hematology analyzers’ technology is essential for screening patients and early identification of infection. Studies indicate that blood analysis is an effective method for identifying and monitoring infections, as well as using point-of-care devices to reduce contamination risks. Here are a few reasons business is improving for hematology analyzer manufacturing companies.

Sales are up worldwide in response to the increase in blood abnormalities. More than 1 million men across the globe experience inherited bleeding disorders from a relative. Early diagnosis is the only way to positively influence health outcomes for those patients. Experts predict that hemophilia is a reality for 17 out of 100,000 male patients worldwide. This inherited blood disorder is one of many abnormalities, which a hematology analyzer may quickly identify. Increasing blood disorders coupled with the persistent presence of COVID variants may drive market sales for hematology analyzers in the near future.

Blood analysis may identify COVID risk factors. A study published in 2020, points to high enzyme levels for blood clot prevention is a risk factor for patients with regard to developing COVID-19. Consequently, managing and treating patients with abnormal hematology test results is of crucial importance. These factors are contributing to the rise in demand for hematology analyzers. With sales skyrocketing, companies are working to improve technology for hematology analyzers and the blood analysis process. As a global issue, hematology disorders, such as infections, anemia, and cancers, impact millions of every socio-economic group. Millions of infants are born globally with blood disorders and 7% of women carry a blood disorder trait. Translating to 1% of the global population impacted by hematological abnormalities, the international hematology analyzer market continues to grow.

Automated technology for hematology analyzer equipment is making the equipment more attractive to doctors who want to reduce blood analysis timeframes. Strict regulations and costs are two barriers to access for smaller medical organizations. However, these factors are not hindering market growth. Utilized by medical professionals and laboratories to test blood samples, hematology analyzers provide efficient results for blood counts, analysis, and coagulation testing. The market includes various sectors, such has researchers, hospitals, and laboratories.

As the need for blood analysis continues to grow globally, the business outlook for hematology analyzer manufacturers and distributors is looking up. Expanded distribution of technologically advanced hematology analyzers is increasing in developed and underdeveloped countries. By offering efficient and effective blook analysis solutions, hematology equipment providers positively impact global health outcomes, which sparks growth in the business market for applicable equipment.